Pegnivacogin (RB006), a Direct Factor IXa Inhibitor, Results in Consistent and Near Complete Inhibition of Factor IX Activity in Patients with Acute Coronary.
Factor IXa Inhibition Aptamer Technology Overview and First Results with RB006/RB007
